ISSN 2412-4036 (print)
ISSN 2713-1823 (online)

Prevention of progression of chronic heart failure with preserved ejection fraction: Estimation of the correlation between NT-proBNP levels and clinical and functional characteristics during control of the disease

Gerasimenko O.N., Zhamalov L.M., Nikolaev K.Yu., Zimina Yu.D., Tolmacheva A.A.

1) Novosibirsk State Medical University of the Ministry of Healthcare of Russia; 2) National Medical Research Center of Therapy and Preventive Medicine of the Ministry of Healthcare of Russia, Moscow; 3) Research Institute of Therapy and Preventive Medicine – a branch of the Federal Research Center, Institute of Cytology and Genetics of Siberian branch of the Russian Academy of Sciences, Novosibirsk
Abstract. A promising direction of modern medicine development is the implementation of point-of-care diagnostic methods, which allows to optimize primary and secondary prevention, as well as treatment strategies for patients with chronic non-infectious diseases. The aim: to evaluate the correlation between N-terminal propeptide of B-type natriuretic hormone (NT-proBNP) level and clinical and functional parameters in patients with chronic heart failure with preserved ejection fraction (CHFpEF) to optimize secondary prevention strategies. Material and methods. Current research work was performed from November 1, 2022, to December 1, 2024, at Novosibirsk Regional Clinical Hospital for War Veterans No. 3. The study included 149 individuals (96 male and 53 female) with a history of myocardial infarction and CHFpEF. Their clinical and functional characteristics were assessed, and NT-proBNP concentrations in the blood were measured using the NT-proBNP K rapid test. Results. A statistically significant correlation was found between NT-proBNP level measured using the rapid test and left vpentricular ejection fraction (r = -0.335; p < 0.01), 6-minute walking test results (r = -0.230, p < 0.01), RSCS indexes (r = 0.650, p < 0.01), as well as with main clinical characteristics of CHF – pulmonary rales (r = 0.626, p < 0.01), orthopnea (r = 0.516, p < 0.01), edema (r = 0.465, p < 0.01), shortness of breath (r = 0.396, p < 0.01), coughing (r = 0.369, p < 0.01). Conclusion. Regular NT-proBNP monitoring serves as a secondary prevention tool, enabling preclinical diagnosis of cardiac dysfunction and timely treatment. A rapid, quantitative method for determining this biomarker has significant diagnostic potential in internal medicine for patients with CHFpEF.

Keywords

chronic heart failure
diagnosis of chronic heart failure
prevention of chronic heart failure
NT-proBNP rapid measurement method

References

1. Мамедов М.Н., Куценко В.А., Драпкина О.М., Балыкова Л.А., Друк И.В., Григорович М.С. с соавт. Возможности и ограничения реализации вторичной профилактики хронических неинфекционных заболеваний по данным опроса российских врачей амбулаторного звена здравоохранения. Кардиоваскулярная терапия и профилактика. 2024;23(8): 67–78. (Mamedov MN, Kutsenko VA, Drapkina OM, Balykova LA, Druk IV, Grigorovich MS et al. Potential and limitations of secondary prevention of noncommunicable diseases: Data from a survey of Russian outpatient physicians. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2024;23(8): 67–78 (In Russ.)).

EDN MCHBYZ. https://doi.org/10.15829/1728-8800-2024-4067

2. Поляков Д.С., Фомин И.В., Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т., Артемьева Е.Г. с соавт. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021;61(4):4–14. (Polyakov DS, Fomin IV, Belenkov YuN, Mareev VYu, Ageev FT, Artemjeva EG et al. Chronic heart failure in the Russian Federation: What has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiya = Cardiology. 2021;61(4):4–14 (In Russ.)).

EDN: WSZNFS. https://doi.org/10.18087/cardio.2021.4.n1628

3. Панарина А.Я., Лифшиц Г.И. Ассоциация генетических полиморфизмов мозгового натрийуретического пептида с сердечно-сосудистыми заболеваниями. Российский кардиологический журнал. 2024;29(10):102–106. (Panarina AYa, Lifshits GI. Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2024;29(10):102–106 (In Russ.)).

EDN: UGAWRK. https://doi.org/10.15829/1560-4071-2024-5906

4. Галявич А.С., Терещенко С.Н., Ускач Т.М., Агеев Ф.Т., Аронов Д.М., Арутюнов Г.П. с соавт. Хроническая сердечная недостаточность. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(11):251–349. (Galyavich AS, Tereshchenko SN, Uskach TM, Ageev FT, Aronov DM, Arutyunov GP et al. 2024 clinical practice guidelines for chronic heart failure. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2024;29(11):251–349 (In Russ.)).

EDN: WKIDLJ. https://doi.org/10.15829/1560-4071-2024-6162

5. Михеева О.О., Домогатский С.П., Ефремов Е.Е., Есипов Р.С. Молекулярные маркеры диагностики сердечной недостаточности. Кардиологический вестник. 2018;13(4):62–67. (Mikheeva OO, Domogatsky SP, Efremov EE, Esipov RS. Molecular markers for diagnostics of cardiac failure. Kardiologicheskiy vestnik = Russian Cardiology Bulletin. 2018;13(4):62–67 (In Russ.)).

EDN: YWBAWD. https://doi.org/10.17116/Cardiobulletin20181304162

6. Николаев К.Ю., Шилова А.В., Ковалева А.Я., Лифшиц Г.И. Роль мозгового натрийуретического пептида в патогенезе резистентной артериальной гипертензии. Российский кардиологический журнал. 2023;28(1):111–116. (Nikolaev KYu, Shilova AV, Kovaleva AYa, Lifshits GI. Role of brain natriuretic peptide in the pathogenesis of resistant hypertension. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2023;28(1):111–116 (In Russ.)).

EDN SCOROR. https://doi.org/10.15829/1560-4071-2023-5188

7. Иосифов А.В., Штегман О.А. Применимость прикроватной диагностики хронической сердечной недостаточности с помощью экспресс-теста для полуколичественного определения уровня NT-proBNP. Кардиология. 2024;64(7):27–30. (Iosifov AV, Shtegman OA. Utility of point-of-care diagnosis of chronic heart failure using an express test for semi-quantitative determination of NT-proBNP levels. Kardiologiya = Cardiology. 2024;64(7):27–30 (In Russ.)).

EDN: DXDRCG. https://doi.org/10.18087/cardio.2024.7.n2647

8. Maisel AS, Shah KS, Barnard D, Jaski B, Frivold G, Marais J et al. How B-type natriuretic peptide (BNP) and body weight changes vary in heart failure with preserved ejection fraction compared with reduced ejection fraction: Secondary results of the HABIT (HF Assessment with BNP In The home) trial. J Card Fail. 2016;22(4):283–93.

PMID: 26433086. https://doi.org/10.1016/j.cardfail.2015.09.014

9. Барбараш О.Л., Карпов Ю.А., Панов А.В., Акчурин Р.С., Алекян Б.Г., Алехин М.Н. с соавт. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(9):166–229. (Barbarash OL, Karpov YuA, Panov AV, Akchurin RS, Alekyan BG, Alekhin MN et al. 2024 Clinical practice guidelines for stable coronary artery disease. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2024;29(9):166–229 (In Russ.)).

EDN: HHJJUT. https://doi.org/10.15829/1560-4071-2024-6110

10. Зимина Ю.Д., Герасименко О.Н., Толмачева А.А. Влияние медицинской реабилитации на годичный прогноз у пациентов с хронической сердечной недостаточностью. Терапия. 2025;11(3):51–57. (Zimina YuD, Gerasimenko ON, Tolmacheva AA. Influence of medical rehabilitation at the annual prognosis for chronic heart failure patients. Terapiya = Therapy. 2025;11(3):51–57 (In Russ.)).

EDN LKMQZU. https://doi.org/10.18565/therapy.2025.3.51-57

11. Рябов В.В., Кручинкина Е.В., Вышлов Е.В., Гусакова А.М., Аникина Д.В., Пантелеев О.О. с соавт. Возможности использования экспресс-тестов NT-proBNP и sST2 у пациентов с острым инфарктом миокарда. Российский кардиологический журнал. 2023;28(6):59–64. (Ryabov VV, Kruchinkina EV, Vyshlov EV, Gusakova AM, Anikina DV, Panteleev OO et al. Potential of NT-proBNP and sST2 rapid tests in patients with acute myocardial infarction. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2023;28(6):59–64 (In Russ.)).

EDN FVEYDB. https://doi.org/10.15829/1560-4071-2023-5379

About the Authors

Oksana N. Gerasimenko, MD, Dr. Sci. (Medicine), professor, head of the Department of faculty therapy named after professor G.D. Zalessky of the Faculty of general medicine, Novosibirsk State Medical University of the Ministry of Healthcare of Russia. Address: 630091, Novosibirsk, 52 Krasny Avenue.
E-mail: profgerasimenko@inbox.ru
ORCID: https://orcid.org/0000-0002-9742-0479
Linar M. Zhamalov, MD, physician-methodologist of the Department of monitoring the organization of medical care of the Center for Organizational and Methodological Management and Analysis of the Quality of Medical Care in the Regions, assistant at the Department of public health and healthcare organization of the Institute of Professional Education and Accreditation, National Medical Research Center of Therapy and Preventive Medicine of the Ministry of Healthcare of Russia; assistant at the Department of internal medicine and family medicine, Omsk State Medical University of the Ministry of Healthcare of Russia. Address: 101990, Moscow, 10/3 Petroverigsky Lane.
E-mail: L.m.zhamalov@mail.ru
Konstantin Yu. Nikolaev, MD, Dr. Sci. (Medicine), professor, chief researcher with the acting title of head of the Department of emergency therapy, Research Institute of Therapy and Preventive Medicine – a branch of the Federal Research Center, Institute of Cytology and Genetics of Siberian branch of the Russian Academy of Sciences. Address: 630089, Novosibirsk, 175/1 B. Bogatkova St.
E-mail: nikolaevky@yandex.ru
ORCID: https://orcid.org/0000-0003-4601-6203
Yulia D. Zimina, MD, postgraduate student of the Department of faculty therapy named after professor G.D. Zalessky of the Faculty of general medicine, Novosibirsk State Medical University of the Ministry of Healthcare of Russia. Address: 630091, Novosibirsk, 52 Krasny Avenue.
E-mail: yulya_tx@mail.ru
ORCID: https://orcid.org/0000-0001-9027-6884
Anastasia A. Tolmacheva, MD, PhD (Medicine), assistant at the Department of faculty therapy named after professor G.D. Zalessky of the Faculty of general medicine, Novosibirsk State Medical University of the Ministry of Healthcare of Russia. Address: 630091, Novosibirsk, 52 Krasny Avenue.
E-mail: tolmacheva_nastena@mail.ru
ORCID: https://orcid.org/0000-0003-1687-4100

Similar Articles